The Infant Formula and Follow-on Formula (Amendment) Regulations 1997
Title, commencement and interpretation1.
(1)
These Regulations may be cited as the Infant Formula and Follow-on Formula (Amendment) Regulations 1997 and shall come into force on 31st March 1997.
(2)
Amendment of the principal Regulations2.
The principal Regulations shall be amended as follows—
(a)
““food authority” does not include—
(a)
the council of a district in a non-metropolitan county in England except where the county functions have been transferred to that council pursuant to a structural change; or
(b)
the appropriate Treasurer referred to in section 5(1)(c) of the Act (which deals with the Inner Temple and the Middle Temple);”;
(b)
in paragraph (c) of regulation 3 after “14” there shall be inserted “, 14A”;
(c)
in sub-paragraph (c) of paragraph (1) of both regulation 5 and 6 for the words “the Food (Lot Marking) Regulations 1992” there shall be substituted the words “the Food (Lot Marking) Regulations 1996”;
(d)
in regulation 12 after the word “infants” there shall be inserted the words “and young children”;
(e)
in both sub-paragraph (e) of paragraph (1) of regulation 13 and sub-paragraph (d) of regulation 14 (which regulations deal, respectively, with the labelling of infant formulae and of follow-on formulae), after the word “carbohydrates” there shall be inserted the words “, expressed in numerical form,”;
(f)
in both sub-paragraph (f) of paragraph (1) of regulation 13 and sub-paragraph (e) of regulation 14, for the words “and carnitine” there shall be substituted the words “, carnitine and taurine, expressed in numerical form,”;
(g)
“(4)
The labelling of an infant formula may include the average quantity of nutrients mentioned in Schedule 3 when such is not covered by the provisions of paragraph (1)(f) above, expressed in numerical form, per 100 millilitres of the product ready for use.”;
(h)
“14A.
The labelling of a follow-on formula may include the average quantity of nutrients mentioned in Schedule 3 when such is not covered by the provisions of regulation 14(e), expressed in numerical form, per 100 millilitres of the product ready for use and, in addition, information on vitamins and minerals included in Schedule 8, expressed as a percentage of the reference values given in that Schedule, per 100 millilitres of the product ready for use, provided that the quantities present are at least equal to 15 per cent of the reference value.”;
(i)
“(3)
Where an offence under these Regulations is committed by a Scottish partnership and is proved to have been committed with the consent or connivance of, or to be attributable to any neglect on the part of, a partner, he as well as the partnership shall be guilty of the offence and be liable to be proceeded against and punished accordingly.”;
(j)
in Schedule 1 (essential composition of infant formulae when reconstituted as instructed by the manufacturer)—
(i)
“Protein2.
(Protein content = nitrogen content × 6.38) for cows’ milk proteins.
(Protein content = nitrogen content × 6.25) for soya protein isolates and protein partial hydrolysates.
The “chemical index” shall mean the lowest of the ratios between the quantity of each essential amino acid of the test protein and the quantity of each corresponding amino acid of the reference protein.
2.1.
Formulae manufactured from cows’ milk proteins
Minimum
Maximum
0.45g/100 kJ
0.7g/100 kJ
(1.8g/100 kcal)
(3g/100 kcal)
For an equal energy value, the formula must contain an available quantity of each essential and semi-essential amino acid at least equal to that contained in the reference protein (breast milk, as defined in Schedule 5); nevertheless, for calculation purposes, the concentration of methionine and cystine may be added together.
2.2.
Formulae manufactured from protein partial hydrolysates
Minimum
Maximum
0.56 g/100 kJ
0.7g/100 kJ
(2.25g/100 kcal)
(3g/100 kcal)
For an equal energy value, the formula must contain an available quantity of each essential and semi-essential amino acid at least equal to that contained in the reference protein (breast milk, as defined in Schedule 5); nevertheless, for calculation purposes, the concentration of methionine and cystine may be added together.
The protein efficiency ratio (PER) and the net protein utilisation (NPU) must be at least equal to those of casein.
The taurine content shall be equal to at least 10 μmoles/100 kJ (42 μmoles/100 kcal) and the L-carnitine content shall be equal to at least 1.8 μmoles/100 kJ (7.5 μmoles/100 kcal).”;
(ii)
“(Minimum)
1.05g/100 kJ
(4.4g/100 kcal)”;
(iii)
in paragraph 3.1 the words “—fats containing more than 8% trans isomers of fatty acids” shall be deleted;
(iv)
“3.5.
The alpha-linolenic acid content shall not be less than 12 mg/100 kJ (50 mg/100 kcal).
The linoleic/alpha-linolenic acid ratio shall not be less than 5 nor greater than 15.
3.6.
The trans fatty acid content shall not exceed 4% of the total fat content.
3.7.
The erucic acid content shall not exceed 1% of the total fat content.
3.8.
Long chain (20 and 22 carbon atoms) polyunsaturated fatty acids (LCP) may be added. In that case their content shall not exceed:
1% of the total fat content for n-3 LCP, and
2% of the total fat content for n-6 LCP (1% of the total fat content for arachidonic acid)
The eicosapentaenoic acid (20:5 n-3) content shall not exceed that of docosahexaenoic (22:6 n-3) acid content.”;
(v)
“(per 100 kJ)
(per 100 kcal)
(minimum)
(maximum)
(minimum)
(maximum)
Selenium(2) (μg)
—
0.7
—
3”,
- and after the first footnote to that paragraph there shall be inserted the following footnote—
“(2)
Limit applicable to formulae with added selenium.”;
(vi)
“(per 100 kJ)
(per 100 kcal)
(minimum)
(maximum)
(minimum)
(maximum)
Niacin (mg-NE)
0.2
—
0.8
—”;
(vii)
“7.
The following nucleotides may be added:
maximum*(mg/100 kJ)
(mg/100 kcal)
cytidine 5'-monophosphate
0.60
2.50
uridine 5'-monophosphate
0.42
1.75
adenosine 5'-monophosphate
0.36
1.50
guanosine 5'-monophosphate
0.12
0.50
inosine 5'-monophosphate
0.24
1.00”;
(k)
in Schedule 2 (essential composition of follow-on formulae when reconstituted as instructed by the manufacturer)—
(i)
in paragraph 2—
(aa)
in the first sub-paragraph following the statement of minimum and maximum amounts, after the word “casein” there shall be inserted the words “or breast milk”;
(bb)
“For an equal energy value, these formulae must contain an available quantity of methionine at least equal to that contained in breast milk as defined in Schedule 5.”;
(ii)
in paragraph 3.1 the words “—fats containing more than 8% trans isomers of fatty acids” shall be deleted;
(iii)
“3.5.
The trans fatty acid content shall not exceed 4% of the total fat content.
3.6.
The erucic acid content shall not exceed 1% of the total fat content.”;
(iv)
“7.
The following nucleotides may be added:
maximum*(mg/100 kJ)
(mg/100 kcal)
cytidine 5'-monophosphate
0.60
2.50
uridine 5'-monophosphate
0.42
1.75
adenosine 5'-monophosphate
0.36
1.50
guanosine 5'-monophosphate
0.12
0.50
inosine 5'-monophosphate
0.24
1.00”;
(l)
in Schedule 3 (nutritional substances)—
(i)
“(Mineral substances)
(Permitted salts)
Selenium (Se)
Sodium selenate
Sodium selenite;”
(ii)
“Cytidine 5'-monophosphate and its sodium salt
Uridine 5'-monophosphate and its sodium salt
Adenosine 5'-monophosphate and its sodium salt
Guanosine 5'-monophosphate and its sodium salt
Inosine 5'-monophosphate and its sodium salt”;
(m)
“(Claim related to)
(Conditions warranting the claim)
7.
Reduction of risk to allergy to milk proteins. This claim may include terms referring to reduced allergen or reduced antigen properties.
(a)
The formulae shall satisfy the provisions laid down in paragraph 2.2 of Schedule 1 and the amount of immunoreactive protein measured with methods generally acceptable as appropriate shall be less than 1% of nitrogen-containing substances in the formulae;
(b)
the label shall indicate that the product must not be consumed by infants allergic to the intact proteins from which it is made unless generally accepted clinical tests provide proof of the formulae’s tolerance in more than 90% of infants (confidence interval 95%) hypersensitive to proteins from which the hydrolysate is made;
(c)
the formulae administered orally should not induce sensitisation, in animals, to the intact proteins from which the formulae are derived;
(d)
objective and scientifically verified data as proof to the claimed properties must be available.”;
(n)
“SCHEDULE 8REFERENCE VALUES FOR NUTRITION LABELLING FOR FOODS INTENDED FOR INFANTS AND YOUNG CHILDREN
Nutrient
Labelling reference value
Vitamin A
(μg)
400
Vitamin D
(μg)
10
Vitamin C
(mg)
25
Thiamin
(mg)
0.5
Riboflavin
(mg)
0.8
Niacin equivalents
(mg)
9
Vitamin B6
(mg)
0.7
Folate
(μg)
100
Vitamin B12
(μg)
0.7
Calcium
(mg)
400
Iron
(mg)
6
Zinc
(mg)
4
Iodine
(μg)
70
Selenium
(μg)
10
Copper
(mg)
0.4”
Transitional provision3.
In any proceedings in respect of any sale or export before 31st March 1999 which is alleged to constitute a contravention of regulation 2, 3, 5, 6 or 7 of the principal Regulations the defendant shall not be convicted of an offence under regulation 22 of the principal Regulations if that sale or export would not have been a contravention of regulation 2, 3, 5, 6 or 7, as appropriate, of the principal Regulations before amendment by these Regulations.
Signed by authority of the Secretary of State for Health:
Signed by authority of the Secretary of State for Wales:
These Regulations, which apply to Great Britain, come into force on 31st March 1997.
The Regulations amend The Infant Formula and Follow-on Formula Regulations 1995 (S.I. 1995/77) (“the principal Regulations”), which implemented inter alia Commission Directive 91/321/EEC (OJ No. L175, 4.7.91, p.35) on infant formulae and follow-on formulae, so as to take account of amendments made to that Directive by Commission Directive 96/4/EC (OJ No. L49, 28.2.96, p.12).
The amendments now being made relate to the labelling of infant and follow-on formulae (regulation 2(e), (f), (g) and (h)), and to compositional criteria etc. including those contained in various Schedules (regulation 2(d), (j), (k), (l) and (m)). A new schedule, Schedule 8 (reference values for nutrition labelling for foods intended for infants and young children), is added (regulation 2(n)).
The definition of “food authority” is amended to take account of changes brought about by local government reorganisation (regulation 2(a)). There is an amendment to regulation 3 so that the sale of infant formulae or follow-on formulae which do not comply with the labelling requirements of regulation 14A (inserted in the principal Regulations by these Regulations) is prohibited (regulation 2(b)). References to the Food (Lot Marking) Regulations are updated (regulation 2(c)) and a provision is inserted in relation to offences committed by Scottish partnerships and partners (regulation 2(i)).
Regulation 3 contains a transitional provision which provides that it is not an offence, before 31st March 1999, to sell or export infant formulae or follow-on formulae which do not comply with the principal Regulations but which do comply with the provisions of the principal Regulations before amendment by these Regulations.
A Compliance Cost Assessment in relation to these Regulations has been placed in the libraries of both Houses of Parliament and copies can be obtained from the Food Labelling and Standards Division of the Ministry of Agriculture, Fisheries and Food, Ergon House, 17 Smith Square, London SW1P 3JR.